Effectiveness of biologic switching in a real-life, Belgian severe asthma cohort.

Lafarge, Lucie; Pilette, Charles; Bugli, Céline; Froidure, Antoine

doi:10.1002/iid3.70023

Effectiveness of biologic switching in a real-life, Belgian severe asthma cohort.

Lafarge, Lucie

;

Pilette, Charles

;

Bugli, Céline

;

Froidure, Antoine

(2024) Immunity, Inflammation and Disease — Vol. 12, n° 10, p. e70023 [1-16] (2024)

Files

LafargeetalImmunityInflamDisease-2024-EffectivenessofbiologicswitchinginareallifeBelgiansevereasthma.pdf

Open Access
Adobe PDF
419.21 KB

Download

Details

Authors

Lafarge, LucieUCLouvain
Author
Pilette, CharlesUCLouvain
Author
Bugli, CélineUCLouvain
Author
Froidure, AntoineUCLouvain
Author

Abstract

In this observational study, we show that switching biologics in severe asthma results in a high proportion of controlled patients.

Affiliations

UCLouvainSSS/IREC/LUNS - Pôle pneumologie, ORL (airways) et dermatologie (skin)
UCLouvainSSH/LIDAM/SMCS - Support en méthodologie et calcul statistique (plate-forme technologique)
UCLouvain(SLuc) Service de pneumologie

Citations

APA
Chicago
FWB

Lafarge, L., Pilette, C., Bugli, C., & Froidure, A. (2024). Effectiveness of biologic switching in a real-life, Belgian severe asthma cohort. Immunity, Inflammation and Disease, 12(10), e70023 [1-16]. https://doi.org/10.1002/iid3.70023 (Original work published 2024)